IT1243358B - Composizioni farmaceutiche per la somministrazione orale di irudina - Google Patents

Composizioni farmaceutiche per la somministrazione orale di irudina

Info

Publication number
IT1243358B
IT1243358B IT02102190A IT2102190A IT1243358B IT 1243358 B IT1243358 B IT 1243358B IT 02102190 A IT02102190 A IT 02102190A IT 2102190 A IT2102190 A IT 2102190A IT 1243358 B IT1243358 B IT 1243358B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
irudina
oral administration
suitable pharmaceutical
oral route
Prior art date
Application number
IT02102190A
Other languages
English (en)
Other versions
IT9021021A0 (it
IT9021021A1 (it
Inventor
Riccardo Niada
Adriano Butti
Original Assignee
Iketon Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iketon Farmaceutici Srl filed Critical Iketon Farmaceutici Srl
Priority to IT02102190A priority Critical patent/IT1243358B/it
Publication of IT9021021A0 publication Critical patent/IT9021021A0/it
Priority to AT91111733T priority patent/ATE145333T1/de
Priority to DE69123190T priority patent/DE69123190D1/de
Priority to EP91111733A priority patent/EP0468327B1/en
Priority to PT98406A priority patent/PT98406A/pt
Priority to JP3204613A priority patent/JPH04270229A/ja
Priority to IE256691A priority patent/IE912566A1/en
Publication of IT9021021A1 publication Critical patent/IT9021021A1/it
Application granted granted Critical
Publication of IT1243358B publication Critical patent/IT1243358B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • A61K38/58Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT02102190A 1990-07-23 1990-07-23 Composizioni farmaceutiche per la somministrazione orale di irudina IT1243358B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT02102190A IT1243358B (it) 1990-07-23 1990-07-23 Composizioni farmaceutiche per la somministrazione orale di irudina
AT91111733T ATE145333T1 (de) 1990-07-23 1991-07-15 Hirudin enthaltende orale arzneimittel
DE69123190T DE69123190D1 (de) 1990-07-23 1991-07-15 Hirudin enthaltende orale Arzneimittel
EP91111733A EP0468327B1 (en) 1990-07-23 1991-07-15 Oral pharmaceutical compositions containing hirudin
PT98406A PT98406A (pt) 1990-07-23 1991-07-22 Processo para a preparacao de composicoes farmaceuticas orais contendo hirudina
JP3204613A JPH04270229A (ja) 1990-07-23 1991-07-22 ヒルジンを含む経口用製薬学的組成物
IE256691A IE912566A1 (en) 1990-07-23 1991-07-22 Oral pharmaceutical compositions containing hirudin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02102190A IT1243358B (it) 1990-07-23 1990-07-23 Composizioni farmaceutiche per la somministrazione orale di irudina

Publications (3)

Publication Number Publication Date
IT9021021A0 IT9021021A0 (it) 1990-07-23
IT9021021A1 IT9021021A1 (it) 1992-01-23
IT1243358B true IT1243358B (it) 1994-06-10

Family

ID=11175506

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02102190A IT1243358B (it) 1990-07-23 1990-07-23 Composizioni farmaceutiche per la somministrazione orale di irudina

Country Status (7)

Country Link
EP (1) EP0468327B1 (it)
JP (1) JPH04270229A (it)
AT (1) ATE145333T1 (it)
DE (1) DE69123190D1 (it)
IE (1) IE912566A1 (it)
IT (1) IT1243358B (it)
PT (1) PT98406A (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0540574T3 (da) * 1990-07-24 1996-09-30 Merrell Pharma Inc Antikoagulationspeptider
NZ268159A (en) * 1993-06-11 1997-03-24 Merrell Pharma Inc Anticoagulant and antiplatelet peptides and their use
GB9401448D0 (en) * 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
WO2003022858A2 (de) * 2001-09-11 2003-03-20 Nascacell Gmbh Verfahren zum screenen von inhibitoren für die protein-protein-wechselwirkung sowie ribozyme hierzu

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3792M (fr) * 1964-08-21 1965-12-27 Egema Médicaments nouveaux a base de constituants actifs extraits de sangsues.
NL7900459A (nl) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D Farmaceutisch preparaat en werkwijze ter bereiding daarvan.
US4348384A (en) * 1980-10-17 1982-09-07 Dainippon Pharmaceutical Co., Ltd. Pharmaceutical composition for oral administration containing coagulation factor VIII or IX
AU3098289A (en) * 1988-03-04 1989-09-07 Biogen, Inc. Hirudin peptides
WO1990006128A1 (en) * 1988-12-05 1990-06-14 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation

Also Published As

Publication number Publication date
DE69123190D1 (de) 1997-01-02
EP0468327A3 (en) 1992-08-26
IE912566A1 (en) 1992-01-29
IT9021021A0 (it) 1990-07-23
JPH04270229A (ja) 1992-09-25
IT9021021A1 (it) 1992-01-23
PT98406A (pt) 1992-05-29
ATE145333T1 (de) 1996-12-15
EP0468327A2 (en) 1992-01-29
EP0468327B1 (en) 1996-11-20

Similar Documents

Publication Publication Date Title
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
ES2080314T3 (es) Composiciones farmaceuticas.
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
SE8402560D0 (sv) Farmaceutisk komposition
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
ITMI912212A0 (it) Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
BE896205A (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
ITRM920535A0 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
DE68903713D1 (de) Dextrorphansalze enthaltende orale arzneimittel.
IT1212137B (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
GB9202993D0 (en) Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
ITPD920141A1 (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
ITMI920214A1 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
ITRM920173A1 (it) Composizione a base di ibuprofen per uso orale.
ITMI931049A1 (it) Composizione farmaceutica mucoadesiva a rilascio controllato per la somministrazione orale di furosemide
IT8323911A0 (it) Composizione farmaceutica per la somministrazione orale di calcitonina.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960725